Safety and Efficacy of Adenovirus Carrying Hepatocyte Growth Factor Gene by Percutaneous Endocardial Injection for Treating Post-infarct Heart Failure: A Phase IIa Clinical Trial-Reference-Cited by-同舟云学术

Safety and Efficacy of Adenovirus Carrying Hepatocyte Growth Factor Gene by Percutaneous Endocardial Injection for Treating Post-infarct Heart Failure: A Phase IIa Clinical Trial

Published:2018-05-07 Issue:2 Volume:18 Page:125-130
ISSN:1566-5232
Container-title:Current Gene Therapy
language:en
Short-container-title:CGT

Author:

Meng Haoyu¹,Chen Bo¹,Tao Zhengxian¹,Xu Zhihui¹,Wang Liansheng¹,Weizhu Ju¹,Hong Yongyong¹,Liu Xiang²,Wang Hua³,Wang Lisheng³,Wu Zuze³,Yang Zhijian¹

Affiliation:

1. Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. Department of Technological, MicroPort Medical Co. Ltd., Shanghai, China

3. Department of Experimental Hematology, Beijing Institute of Radiation Medicine of China, Academy of Military Medical Sciences, Beijing, China

Publisher

Bentham Science Publishers Ltd.

Subject

Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for atrial fibrillation;Journal of Molecular and Cellular Cardiology;2024-11

2. The Functions and Application Prospects of Hepatocyte Growth Factor in Reproduction;Current Gene Therapy;2024-10

3. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

4. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure;Journal of Cardiac Failure;2023-06

5. Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model;Journal of Cardiovascular Development and Disease;2023-02-17